Loading the security overview…
Where the tokens are
Trade LRCX
Trade LRCX perpsStandardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q4 FY262026-06-28 | Q3 FY262026-03-29 | Q2 FY262025-12-28 | Q1 FY262025-09-28 | Q4 FY252025-06-29 | Q3 FY252025-03-30 | Q2 FY252024-12-29 | Q1 FY252024-09-29 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.72B | $5.84B | $5.34B | $5.32B | $5.17B | $4.72B | $4.38B | $4.17B |
| Cost of revenue | $3.24B | $2.93B | $2.69B | $2.64B | $2.58B | $2.41B | $2.30B | $2.17B |
| Gross profit | $3.48B | $2.91B | $2.65B | $2.68B | $2.59B | $2.31B | $2.07B | $2.00B |
| Gross margin | 51.7% | 49.8% | 49.6% | 50.4% | 50.1% | 49.0% | 47.4% | 48.0% |
| Research and development | $642.92M | $583.20M | $573.31M | $576.45M | $580.18M | $525.90M | $494.95M | $495.36M |
| Selling, general and administrative | $322.33M | $280.31M | $267.65M | $279.35M | $268.40M | $226.02M | $244.15M | $243.13M |
| Operating expenses | $965.25M | $863.51M | $840.96M | $855.79M | $848.58M | $751.93M | $739.10M | $738.49M |
| Operating income | $2.51B | $2.05B | $1.81B | $1.83B | $1.74B | $1.56B | $1.33B | $1.26B |
| Operating margin | 37.4% | 35.0% | 33.9% | 34.4% | 33.7% | 33.1% | 30.5% | 30.3% |
| EBITDA | $2.63B | $2.16B | $1.91B | $1.93B | $1.84B | $1.66B | $1.43B | $1.36B |
| Interest income | $196.19M | $0 | $0 | — | $231.33M | $0 | $0 | — |
| Interest expense | −$156.88M | $0 | $0 | — | −$178.20M | $0 | $0 | — |
| Income before taxes | $2.56B | $2.01B | $1.84B | $1.86B | $1.78B | $1.54B | $1.35B | $1.29B |
| Income taxes | $277.86M | $186.10M | $242.62M | $290.50M | $58.89M | $206.06M | $157.13M | $177.83M |
| Net income | $2.28B | $1.83B | $1.59B | $1.57B | $1.72B | $1.33B | $1.19B | $1.12B |
| Net margin | 33.9% | 31.2% | 29.8% | 29.5% | 33.3% | 28.2% | 27.2% | 26.8% |
| EPS, basic | $1.82 | $1.46 | $1.27 | $1.24 | $1.35 | $1.04 | $0.93 | $0.86 |
| EPS, diluted | $1.81 | $1.45 | $1.26 | $1.24 | $1.35 | $1.03 | $0.92 | $0.86 |
| Diluted shares | 1.26B | 1.26B | 1.26B | 1.27B | 1.28B | 1.29B | 1.29B | 1.30B |
Figures describe Lam Research Corporation shares, not any token. As of Aug 7, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.